Literature DB >> 31934559

Suppurative Lymphadenitis after Radioactive Iodine Therapy for Graves' Disease: A Rare Complication?

Shi Hui Junice Wong1.   

Abstract

BACKGROUND: Radioiodine (RAI) therapy for Graves' disease is a well-accepted and effective treatment with a good side effect profile. Short-term adverse effects can occasionally include radiation-induced thyroiditis. To my knowledge, cervical lymphadenitis associated with RAI therapy for Graves' disease has not been reported before. CASE REPORT: A 38-year-old woman initially presented with uncontrolled thyrotoxicosis secondary to Graves' disease. She subsequently received RAI therapy for her condition. Within a week, she developed painful bilateral cervical lymphadenopathy that progressed to abscess formation requiring incision and drainage. No other causes (neoplastic or infective) were found. Symptomatic treatment was instituted, and within 2 months the lymphadenitis resolved completely. DISCUSSION: RAI therapy for Graves' disease can sometimes cause radiation-induced thyroiditis but associated cervical lymphadenopathy or lymphadenitis has not been described. This may represent a continuum of the proinflammatory state induced by RAI manifesting as a rare but potentially morbid complication.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Graves' disease; Hyperthyroidism; Lymphadenitis; Lymphadenopathy; Radioiodine therapy

Year:  2019        PMID: 31934559      PMCID: PMC6944909          DOI: 10.1159/000503457

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  7 in total

1.  Hyperthyroidism treated with radioiodine; a seven-year experience.

Authors:  W H BEIERWALTES; P C JOHNSON
Journal:  AMA Arch Intern Med       Date:  1956-04

2.  Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage.

Authors:  Sergio Hernández-Jiménez; Alvaro Pachón-Burgos; Carlos Alberto Aguilar-Salinas; Víctor Andrade; Ricardo Reynoso; Aurelio Ríos; Alfredo Adolfo Reza-Albarrán; Roopa Mehta; Ofelia González-Treviño; Francisco Javier Gómez-Pérez; Bernardo Pérez-Enríquezi; Juan A Rull
Journal:  Arch Med Res       Date:  2007-02       Impact factor: 2.235

Review 3.  Radioiodine therapy for hyperthyroidism.

Authors:  Douglas S Ross
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

4.  Painful Radiation Thyroiditis after 131I Therapy for Graves' Hyperthyroidism: Clinical Features and Ultrasonographic Findings in Five Cases.

Authors:  Tetsuya Mizokami; Katsuhiko Hamada; Tetsushi Maruta; Kiichiro Higashi; Junichi Tajiri
Journal:  Eur Thyroid J       Date:  2016-09-06

5.  Painful acute radiation thyroiditis induced by 131I treatment of Graves' disease.

Authors:  Kinjal K Shah; Valentina Tarasova; Michael Davidian; Robert J Anderson
Journal:  BMJ Case Rep       Date:  2015-01-09

6.  [Evaluation of radioiodine therapy with fixed doses of 10 and 15 mCi in patients with Graves' disease].

Authors:  Viviane Canadas; Lucio Vilar; Eliane Moura; Ana Brito; Enio Castellar
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-10

Review 7.  Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.

Authors:  Steen Joop Bonnema; Laszlo Hegedüs
Journal:  Endocr Rev       Date:  2012-09-07       Impact factor: 19.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.